Inactivating variants in ANGPTL4 and risk of coronary artery Disease

Frederick E. Dewey, Viktoria Gusarova, Colm O'Dushlaine, Omri Gottesman, Jesus Trejos, Charleen Hunt, Cristopher V. Van Hout, Lukas Habegger, David Buckler, Ka Man V. Lai, Joseph B. Leader, Michael F. Murray, Marylyn D. Ritchie, H. Lester Kirchner, David H. Ledbetter, John Penn, Alexander Lopez, Ingrid B. Borecki, John D. Overton, Jeffrey G. ReidDavid J. Carey, Andrew J. Murphy, George D. Yancopoulos, Aris Baras, Jesper Gromada, Alan R. Shuldiner

Research output: Contribution to journalArticlepeer-review

392 Scopus citations

Fingerprint

Dive into the research topics of 'Inactivating variants in ANGPTL4 and risk of coronary artery Disease'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science